Network Version
CPDA Data Sheet
| Product Name: | CPDA |
 |
|---|---|---|
| CAS No.: | 1415834-63-7 | |
| Cat. No.: | HY-18685 | |
| MWt: | 388.8 | |
| Formula: | C20H15ClF2N2O2 | |
| Purity : | >98% | |
| Solubility: | DMSO : ≥ 50 mg/mL (128.60 mM) | |
| Mechanisms: | Target: Metabolic Disease | |
| Biological Activity: | ||
| CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor. IC50 & Target: SHIP2 In Vitro: CPDA enhances insulin signaling. In Vivo: CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice. | ||
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com